Sanofi to invest in mRNA vaccines development | The Business Standard
Skip to main content
  • Epaper
  • Economy
    • Aviation
    • Banking
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
The Business Standard

Friday
May 30, 2025

Sign In
Subscribe
  • Epaper
  • Economy
    • Aviation
    • Banking
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
FRIDAY, MAY 30, 2025
Sanofi to invest in mRNA vaccines development

Coronavirus chronicle

Reuters
29 June, 2021, 08:45 pm
Last modified: 29 June, 2021, 08:47 pm

Related News

  • How Renata's Tk1,000cr investment plan became a Tk1,400cr problem
  • Health workers, employed during pandemic, call for job security after four years of service
  • Covid-19 disrupted progress on Measles, Rubella elimination: WHO
  • World better positioned against mpox than for Covid: Vaccine alliance
  • US FDA approves updated Covid shots ahead of fall and winter

Sanofi to invest in mRNA vaccines development

Sanofi added on Tuesday that its "mRNA Center of Excellence" will bring together around 400 employees based at existing sites close to Lyon in southern France and in Cambridge, Massachusetts

Reuters
29 June, 2021, 08:45 pm
Last modified: 29 June, 2021, 08:47 pm
Sanofi to invest in mRNA vaccines development

Sanofi will invest about 400 million euros ($476 million) annually in research and development of next-generation vaccines using mRNA technologies, which proved their efficiency in the Pfizer and Moderna Covid-19 jabs.

Sanofi added on Tuesday that its "mRNA Center of Excellence" will bring together around 400 employees based at existing sites close to Lyon in southern France and in Cambridge, Massachusetts. It is expected to produce a minimum of six clinical candidates by 2025.

"During the Covid-19 pandemic, mRNA technologies demonstrated potential to deliver new vaccines faster than ever before", said Jean-Francois Toussaint, global head of R&D at Sanofi Pasteur, the company's vaccines division.

The Business Standard Google News Keep updated, follow The Business Standard's Google news channel

"However, key areas of innovation such as thermostability and tolerability improvements will be critical to unlock the applications of mRNA in routine vaccination against a broader set of infectious diseases and across all ages," he added.

The French drug company and its British counterpart GlaxoSmithKline disappointed investors and customers late last year when they announced a one-year delay to the launch of their joint Covid vaccine, based on a more conventional technology.

Sanofi has since pledged to help Pfizer and Moderna manufacture Covid-19 shots in an effort to help meet the huge demand for the U.S. drugmaker's doses.

The mRNA technology has proven both effective and safe so far in the vaccine response to Covid-19, including in response to the virus' variants.

The latest one, the Delta variant first found in India, is spreading at a fast rate around the world, prompting governments to accelerate their vaccinations programs.

French Health Minister Oliver Veran said on Tuesday that the Delta variant represented some 20 percent of Covid cases in France.

Sanofi is also working on a mRNA Covid-19 vaccine candidate with U.S. company Translate Bio, for which it has started clinical trials.

The two groups, which have been collaborating since 2018, have also started a Phase I clinical trial earlier this year evaluating an mRNA-based investigational vaccine against seasonal influenza.

Last month, Sanofi and GlaxoSmithKline launched a late-stage human trial for their Covid-19 vaccine candidate, which they hope to get approved by the end of 2021.

($1 = 0.8397 euros)

Sanofi / COVID-19 / mRNA vaccines

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • Deep depression over Bay of Bengal on 29 May. Photo: ANI
    Heavy rain, tidal surges trigger flood warnings as deep depression crosses coast
  • Powerful tidal surges from the Meghna River flooded more than 100 villages in four coastal upazilas of Lakshmipur on 29 May 2025. Photo: TBS
    Meghna tidal surge floods over 100 villages as incessant daylong rain batters Lakshmipur
  • Attackers vandalise the windows of the residence of Jatiyo Party (JaPa) Chairman GM Quader and set fire to a motorcycle in Rangpur on 29 May 2025. Photo: TBS
    Jatiyo Party chief GM Quader's Rangpur house attacked; NCP, SAD activists blamed

MOST VIEWED

  • Dhaka areas at a gridlock on Wednesday, 28 May 2025. Photo: Syed Zakir Hossain/TBS
    BNP, Jamaat rallies: Traffic clogs Dhaka roads, including Motijheel, Paltan, Dainik Bangla intersection
  • IFIC Bank receives Tk6,000 cr in new deposits in six months
    IFIC Bank receives Tk6,000 cr in new deposits in six months
  • Mohammad Abdul Mannan, chairman FSIB Ltd. Sketch: TBS
    FSIB to bounce back soon
  • Abdul Awal Mintoo, chairman of National Bank Limited. Sketch: TBS
    'Regulatory support must for National Bank to restore depositors' confidence'
  • Md Nazrul Islam Swapan, chairman of EXIM Bank. Sketch: TBS
    Exim Bank restored depositors’ confidence, overcoming challenges
  • Mohammad Mamdudur Rashid, managing director and CEO, UCB. Sketch: TBS
    Customers’ trust and confidence fueling deposit growth at UCB

Related News

  • How Renata's Tk1,000cr investment plan became a Tk1,400cr problem
  • Health workers, employed during pandemic, call for job security after four years of service
  • Covid-19 disrupted progress on Measles, Rubella elimination: WHO
  • World better positioned against mpox than for Covid: Vaccine alliance
  • US FDA approves updated Covid shots ahead of fall and winter

Features

For hundreds of small fishermen living near this delicate area, sustainable fishing is a necessity for their survival. Photo: Syed Zakir Hossain

World Ocean Day: Bangladesh’s ‘Silent Island’ provides a fisheries model for the future

11h | The Big Picture
The university will be OK. But will the US? Photo: Bloomberg

A weaker Harvard is a weaker America

11h | Panorama
The Botanical Garden is a refuge for plant species, both native and exotic. Photo: Mehedi Hasan/TBS

The hidden cost of 'development' in the Botanical Garden

11h | Panorama
Stillbirths in Bangladesh: A preventable public health emergency

Stillbirths in Bangladesh: A preventable public health emergency

11h | Panorama

More Videos from TBS

Record migrant deaths in 2024

Record migrant deaths in 2024

8h | Podcast
News of The Day, 29 MAY 2025

News of The Day, 29 MAY 2025

10h | TBS News of the day
Businesses set for relief as interim govt eyes major tax & fine cuts

Businesses set for relief as interim govt eyes major tax & fine cuts

13h | TBS Insight
Love is essential for human life

Love is essential for human life

12h | TBS Programs
EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Advertisement
  • Privacy Policy
  • Comment Policy
Copyright © 2025
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net